Strides Pharma Science shares in focus today; here's why

Strides Pharma stock: The share subscription agreements are being executed at a pre-money equity value of $1.65 billion, delivering to shareholders an embedded value of Rs 663 per share of Strides’ holding in OneSource.
Read The Rest at :